Methods
This study is a retrospective, single center analysis of all patients
receiving apixaban while awaiting cardiac transplantation. Weight-based
dosing was monitored with peak drug-specific anti-Xa chromogenic
analysis. Significant post-operative bleeding defined by chest tube
output or need for surgical intervention.